Month: March 2021

Two drugs, a dietary supplement, and some devices have been recalled for mislabeled dosages, hidden ingredients, possible injuries and more. The recalled items span uses for high blood pressure, herpes infections, sexual enhancement, pre-surgical swabs and children’s cardiac surgery The first recall is for telmisartan, brand name Micardis, which is used to control high blood
0 Comments
Intravitreal injections with aflibercept (Eylea) don’t improve the visual acuity of people with nonproliferative diabetic retinopathy (NPDR), researchers say. The treatments do reduce the risk for center-involved diabetic macular edema and proliferative diabetic retinopathy, however, said Adam R. Glassman, MS, principal investigator of the DRCR Retina Network Coordinating Center, Tampa, Florida. “Some clinicians may decide
0 Comments
For people with diabetes, eating habits need to be strictly monitored or they risk experiencing damaging and even fatal health effects. High sugar foods in particular, are very risky for diabetics. So, is honey good for diabetics? Mismanagement of diabetes can be fatal Diabetes is a disease where your body is unable to regulate blood
0 Comments
As cancer survival rates improve, more people are living with the aftereffects of cancer treatment. For some patients, these issues include chronic radiation-induced skin injury – which can lead to potentially severe cosmetic and functional problems. Recent studies suggest a promising new approach in these cases, using fat grafting procedures to unleash the healing and
0 Comments
maralixibat Treatment for Cholestatic Pruritus in Patients with Alagille Syndrome Mirum Pharmaceuticals Announces FDA Acceptance of New Drug Application and Priority Review for Maralixibat in Alagille Syndrome FOSTER CITY, Calif.–(BUSINESS WIRE)–Mar. 29, 2021– Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) announced today that its New Drug Application (NDA) for maralixibat, an oral apical sodium dependent bile acid transporter (ASBT)
0 Comments
HAMILTON, Bermuda, March 18, 2021 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (Kiniksa), a biopharmaceutical company with a portfolio of assets designed to modulate immunological pathways across a spectrum of diseases, today announced the U.S. Food and Drug Administration (FDA) approved Arcalyst (rilonacept), a weekly, subcutaneously-injected, recombinant fusion protein that blocks interleukin-1 alpha (IL-1α)
0 Comments
News FDA Alerts Namoo Enterprise LLC Issues Voluntary Nationwide Recall of PremierZen Black 5000 Due to the Presence of Undeclared Sildenafil and Tadalafil March 26, 2021 Audience: Consumer March 26, 2021 — Little Ferry, NJ, Namoo Enterprise LLC is voluntarily recalling all lots within expiry of PremierZen Black 5000 capsules to the consumer level. FDA
0 Comments
Researchers at Cincinnati Children’s Hospital Medical Center have developed a new framework for different factors influencing how a child’s brain is “wired” to learn to read before kindergarten. This may help pediatric providers identify risks when the brain is most responsive to experiences and interventions. This “eco-bio-developmental” model of emergent literacy, described in the journal
0 Comments
It pains me to write this. I am tired of pretending. I simply cannot do this anymore. I sincerely wish you well. I do hope our paths will cross again. I first gazed at you, cautiously intrigued — coquettish even. Butterflies fluttered when I thought of you. You left me longing for more details. You
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Two-thirds of epidemiologists from leading academic institutions say the world will need new or modified vaccines for COVID-19 within a year, new research show.. In a survey of 77 epidemiologists from 28 countries by the People’s Vaccine Alliance, 66.2% predicted the
0 Comments
Since the early days of Donald Trump’s campaign, mental health professionals have come forth in unprecedented ways to warn against entrusting the U.S. presidency to someone whose mental fitness for the Oval Office was more than suspect.  In early 2017, I organized an ethics conference at Yale School of Medicine to clarify our public health duty,
0 Comments
Jon Holley is a trauma and orthopaedic surgeon and co-founder of TEDxNHS – a place for empowering talks for the NHS, by the NHS *Trigger warning: Themes around a baby’s death. My beautiful son Theo died seven years ago. Five weeks into his short life, the magical delight and abundant possibility of the night he
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Obesity rates among children jumped substantially in the first months of the COVID-19 pandemic, according to a study published online in Pediatrics. Experts worry the excess weight will be a continuing problem for these children. “Across the board in the span
0 Comments
Cardiovascular disease is the major cause of mortality worldwide.1 In recent years, the mortality associated with cardiovascular disease has decreased in developed countries, however, it is rising in developing countries where the use of preventative medication is lower.2 Cardiovascular disease refers to a range of diseases involving the heart and blood vessels. For example, coronary
0 Comments
President Joe Biden delivers remarks on Covid-19 response and vaccinations in the South Court Auditorium of the White House in Washington DC, on March 29, 2021. Jim Watson | AFP | Getty Images President Joe Biden on Monday urged governors and local leaders who dropped sweeping mask mandates to reinstate their orders, indicated some states
0 Comments
PRINCETON, N.J.–(BUSINESS WIRE) March 25, 2021 — Bristol Myers Squibb (NYSE: BMY) today announced primary results from the Phase 2/3 RELATIVITY-047 (CA224-047) trial evaluating the fixed-dose combination of relatlimab, an anti-LAG-3 antibody, and Opdivo (nivolumab) versus Opdivo alone in patients with previously untreated metastatic or unresectable melanoma. The trial met its primary endpoint of progression-free
0 Comments
TOKYO, March 26, 2021 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) announced today that the U.S. Food and Drug Administration (FDA) approved Myrbetriq (mirabegron extended-release tablets) for the treatment of NDO in pediatric patients aged three years and older who weigh 35 kg or more, and Myrbetriq Granules
0 Comments
March 25, 2021 Audience: Consumer, Patient, Health Professional, Pharmacy March 25, 2021 — Pennington, NJ, Zydus Pharmaceuticals (USA) Inc. is voluntarily recalling four lots of Acyclovir Sodium Injection, 50 mg/mL, 10 mL and 20 mL vials, to the Hospital/User level after receiving several complaints of crystallization in vials. Administration of crystalized Acyclovir Sodium Injection, 50
0 Comments
A review of more than 20 studies by researchers at Arizona State University and the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, suggests that nonalcoholic fatty-liver disease (NAFLD) is a growing dietary problem for children across the globe. The prevalence of fatty-liver disease is escalating not only in adults, but also
0 Comments
Cognitive impairment occurred more than twice as often in patients with normotensive glaucoma (NTG) as compared with high-tension glaucoma (HTG) and exhibited a trend toward greater impairment, a matched case-control study showed. A telephone-based cognitive assessment questionnaire showed that 14.8% of patients with NTG met criteria for cognitive impairment versus 5.4% of patients with HTG.
0 Comments